PRESSEMITTEILUNGEN

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Research & Development/Clinical Data – Sepsis Heidelberg (euro adhoc) – Planegg/Munich (Germany), Princeton, NJ and Houston, TX, January 17, 2011 – Agennix AG (Frankfurt Stock Exchange: AGX) announced that new and more detailed data from a [...]

Continue reading

Agx, Antibacterial Properties, Biologic Therapy, Brown Medical School, Cause Mortality, Critical Care Medicine, Double Blind Placebo, Dr Levy, Frankfurt Stock Exchange, Immunomodulatory, Intensive Care Unit, Medical Intensive Care, Mortality Data, Munich Germany, Planegg, Princeton Nj, Providence Rhode Island, San Diego California, Sepsis, Society Of Critical Care Medicine

——————————————————————————– Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. ——————————————————————————– Forschung/Entwicklung/Schwere Blutvergiftung Heidelberg (euro adhoc) – Planegg/München und US-Standorte in Princeton, NJ, und Houston, TX, 12. Januar 2011 – Die Agennix AG (Frankfurter Wertpapierbörse: AGX) gab heute bekannt, dass neue und detailliertere Daten einer Phase II-Studie mit Talactoferrin bei schwerer [...]

Continue reading

Adhoc, Agennix, Cardiac Dysfunction, Cause Mortality, Corporate News, Critical Care Medicine, Frankfurter, Heidelberg, Infectious Disease, Kalifornien, Kongress, Krebs, Pharmacokinetics, Phase Ii, Placebo, Princeton Nj, Schwere, Sepsis, Septic Shock, Society Of Critical Care Medicine

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Research & Development/Severe Sepsis Heidelberg (euro adhoc) – Planegg/Munich (Germany), Princeton, NJ and Houston, TX, January 12, 2011 – Agennix AG (Frankfurt Stock Exchange: AGX) today announced that new and more detailed data from a Phase [...]

Continue reading

Antibacterial Properties, Biologic Therapy, Cardiac Dysfunction, Cause Mortality, Cell Lung Cancer, Critical Care Medicine, Double Blind Placebo, Frankfurt Stock Exchange, Immunomodulatory, Munich Germany, Non Small Cell Lung Cancer, Oral Session, Princeton Nj, San Diego California, Sepsis, Septic Shock, Small Cell Lung Cancer, Society Of Critical Care Medicine, Treatment Of Cancer, Types Of Cancer

Chicago, November 16 (ots/PRNewswire) – New results from an observational substudy from TRITON-TIMI 38 presented today at the American Heart Association (AHA) Scientific Sessions annual meeting showed that patients treated with Efient(R)/Effient(R) (prasugrel) prior to coronary artery bypass graft surgery (CABG) had a reduced overall mortality rate compared to patients treated with Plavix(R) (clopidogrel) (2.3 [...]

Continue reading

American Heart Association, Artery Bypass Graft Surgery, Bypass Graft Surgery, Cabg, Cardiovascular Death, Cause Mortality, Clopidogrel, Coronary Artery Bypass, Coronary Artery Bypass Graft, Coronary Artery Bypass Graft Surgery, Coronary Artery Bypass Surgery, Duke University Medical, Duke University Medical Center, Mortality Data, Mortality Rate, Peter K Smith, Prasugrel, Prnewswire, Retrospective Analysis, University Medical Center

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Research & Development/Severe Sepsis Heidelberg (euro adhoc) – Planegg/Munich (Germany), Princeton, NJ and Houston, TX, September 3, 2010 – Agennix AG (Frankfurt Stock Exchange: AGX) announced that data from a Phase II trial with talactoferrin in [...]

Continue reading

Adult Patients, Agennix, Brown University Providence, Brown University Providence Rhode Island, Cause Mortality, Controlled Trial, Double Blind Placebo, Frankfurt Stock Exchange, Infectious Disease Division, International Symposium, Logistic Regression Analysis, Munich Germany, Odds Ratio, Paris France, Patient Population, Planegg, Princeton Nj, Providence Rhode Island, Sepsis, Sick Patient

Basel, Switzerland (ots/PRNewswire) – – New Analysis of Data From landmark ‘Valsartan Heart Failure Trial’ Adds to Growing Evidence That Plasma Renin Activity (PRA) is Linked to Cardiovascular Outcomes (1-3) – PRA is a Measure of the Activity of the Renin Angiotensin System (RAS) – The Only High Blood Pressure Treatment That Blocks the RAS [...]

Continue reading

Ace Inhibitor, Ace Inhibitors, Aliskiren, Basel Switzerland, Beta Blocker, Beta Blockers, Blood Pressure Treatment, Cardiovascular Morbidity, Cardiovascular Outcomes, Cause Mortality, Center Florence, Chronic Heart Failure, Esc Congress, European Society Of Cardiology, Florence Italy, Heart Failure, Heart Failure Patients, Heart Failure Trial, Morbidity And Mortality, Plasma Renin Activity

(pressebox) Berlin, 02.12.2008 – BIOTRONIK announces European rollout of the EchoCRT Trial investigating the life-saving benefits of cardiac resynchronization therapy in patients with heart failure who currently do not receive device therapy. BIOTRONIK announced that the first European patients have been enrolled into the EchoCRT (Echocardiography guided Cardiac Resynchronization Therapy) trial by the team of [...]

Continue reading

Barcelona Spain, Biotronik, Cardiac Resynchronization Therapy, Cardiology Department, Cause Mortality, Eligible Patients, European Heart, Executive Committee Member, Heart Failure, Heart Rhythm, Left Ventricular, Medical Therapy, Patients With Heart Failure, Pharmacological Therapy, Professor Dr, Qrs, Randomization, Study Population, Target, Thorax